0,930  0,005  Apoptosis agonist
0,904  0,005  Antiinflammatory
0,877  0,004  Caspase 9 stimulant
0,868  0,009  Transcription factor NF kappa B inhibitor
0,837  0,005  Antineoplastic (lung cancer)
0,830  0,007  Antineoplastic (breast cancer)
0,825  0,004  Nitric oxide antagonist
0,808  0,004  Antineoplastic (melanoma)
0,795  0,005  Chemopreventive
0,789  0,004  Hepatic disorders treatment
0,781  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,763  0,005  Prostate cancer treatment
0,761  0,009  Cyclophilin D inhibitor
0,761  0,009  Antidiabetic
0,751  0,003  Hepatoprotectant
0,746  0,007  Antineoplastic (ovarian cancer)
0,741  0,005  Caspase 3 stimulant
0,740  0,004  Antineoplastic (pancreatic cancer)
0,727  0,003  Phospholipase C inhibitor
0,729  0,008  Chemoprotective
0,711  0,006  5 Hydroxytryptamine release stimulant
0,701  0,003  Antineoplastic (endocrine cancer)
0,708  0,012  Antileukemic
0,679  0,005  Apoptosis antagonist
0,671  0,005  Antineoplastic (multiple myeloma)
0,678  0,015  TNF expression inhibitor
0,659  0,003  ICAM1 expression inhibitor
0,656  0,009  Antineoplastic (cervical cancer)
0,654  0,007  Antidiabetic (type 2)
0,652  0,013  Antihypercholesterolemic
0,612  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,618  0,009  AR expression inhibitor
0,613  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,619  0,016  Cholesterol antagonist
0,594  0,003  Interferon gamma antagonist
0,598  0,006  UGT1A4 substrate
0,603  0,023  Antineoplastic (colorectal cancer)
0,580  0,004  Protein-tyrosine phosphatase inhibitor
0,582  0,007  Vascular (periferal) disease treatment
0,594  0,023  Antineoplastic (colon cancer)
0,560  0,004  Antiviral (Influenza A)
0,568  0,017  Bone diseases treatment
0,550  0,004  Antiviral (Influenza)
0,554  0,012  Antineoplastic (glioma)
0,550  0,015  Antiosteoporotic
0,542  0,016  Antioxidant
0,538  0,019  Cytotoxic
0,524  0,008  Wound healing agent
0,529  0,013  Hypoglycemic
0,529  0,016  NOS2 expression inhibitor
0,528  0,017  NOS3 expression inhibitor
0,522  0,011  Antineoplastic (glioblastoma multiforme)
0,510  0,005  Contraceptive
0,506  0,005  Insulin secretagoues
0,495  0,009  Antineoplastic (liver cancer)
0,497  0,021  Lipoprotein disorders treatment
0,473  0,003  Contraceptive female
0,479  0,014  UGT2B4 substrate
0,474  0,012  Antineoplastic (renal cancer)
0,464  0,008  Abortion inducer
0,443  0,003  Cholesterol synthesis inhibitor
0,446  0,009  Melanin inhibitor
0,442  0,008  Lipid peroxidase inhibitor
0,445  0,011  Antiviral (HIV)
0,430  0,004  Gastrin inhibitor
0,442  0,021  Antipyretic
0,446  0,026  Metabolic disease treatment
0,429  0,011  Diuretic
0,434  0,018  Antihypertriglyceridemic
0,442  0,029  Antineoplastic (brain cancer)
0,456  0,045  Immunosuppressant
0,419  0,011  Prostatic (benign) hyperplasia treatment
0,428  0,020  Hypolipemic
0,421  0,016  Antiulcerative
0,415  0,013  Sodium/bile acid cotransporter inhibitor
0,407  0,006  Antiviral (Hepatitis B)
0,440  0,040  Antithrombotic
0,402  0,003  Inducible nitric-oxide synthase inhibitor
0,408  0,010  Prostate disorders treatment
0,418  0,024  Tumour necrosis factor alpha release inhibitor
0,440  0,052  Antipruritic, allergic
0,383  0,003  Phosphorylase inhibitor
0,375  0,004  Cyclooxygenase 3 inhibitor
0,395  0,026  Antihypoxic
0,379  0,012  Antiviral (Hepatitis)
0,370  0,004  AMP-activated protein kinase stimulant
0,397  0,039  Cardioprotectant
0,414  0,059  CYP3A4 substrate
0,387  0,032  Cardiovascular analeptic
0,364  0,015  UGT2B7 substrate
0,396  0,051  Immunostimulant
0,365  0,038  Antiprotozoal (Leishmania)
0,366  0,039  Sensitization
0,331  0,006  Antiinfertility, female
0,335  0,015  Lipocortins synthesis antagonist
0,339  0,020  Antiviral (Herpes)
0,319  0,012  Antiviral (Hepatitis C)
0,340  0,035  Angiogenesis stimulant
0,344  0,039  Cardiodepressant
0,350  0,046  Interleukin 2 agonist
0,340  0,036  Transcription factor STAT3 inhibitor
0,321  0,017  Hair growth stimulant
0,327  0,026  Platelet adhesion inhibitor
0,331  0,034  Antineoplastic (lymphocytic leukemia)
0,302  0,005  Anticataract
0,334  0,043  Proliferative diseases treatment
0,320  0,034  Antineoplastic (bladder cancer)
0,305  0,022  Antiacne
0,314  0,032  UDP-glucuronosyltransferase substrate
0,344  0,062  Antifungal
0,285  0,004  Transcription factor NF kappa B stimulant
0,291  0,014  Acute respiratory distress syndrome (ARDS) treatment
0,281  0,007  Contraceptive male
0,314  0,043  Carcinogenic
0,283  0,013  UGT2B9 substrate
0,300  0,032  Antihelmintic
0,388  0,120  Alpha-glucosidase inhibitor
0,353  0,088  Atherosclerosis treatment
0,283  0,023  Anesthetic
0,265  0,015  DNA polymerase I inhibitor
0,305  0,055  Antineoplastic (non-small cell lung cancer)
0,260  0,011  Liver cirrhosis treatment
0,292  0,045  Antiparasitic
0,254  0,012  UGT2B10 substrate
0,244  0,004  Androgen agonist
0,259  0,021  Interleukin 6 antagonist
0,264  0,027  Antihelmintic (Nematodes)
0,249  0,013  Antihemorrhagic
0,288  0,052  Vasodilator
0,237  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,238  0,009  Arachidonic acid antagonist
0,235  0,005  Antiprotozoal (Toxoplasma)
0,255  0,026  UGT2B15 substrate
0,237  0,010  Androgen antagonist
0,257  0,030  Insulin sensitizer
0,258  0,032  Antipruritic, non-allergic
0,313  0,090  Vasodilator, peripheral
0,248  0,027  Protein kinase stimulant
0,233  0,013  Microtubule formation inhibitor
0,219  0,004  Lanosterol 14 alpha demethylase inhibitor
0,240  0,028  Skin whitener
0,215  0,007  Postmenopausal disorders treatment
0,208  0,004  Aldosterone antagonist
0,201  0,004  Anabolic
0,206  0,012  HDL-cholesterol increasing
0,196  0,004  Glycine receptor antagonist
0,238  0,045  P-glycoprotein inhibitor
0,263  0,072  Teratogen
0,233  0,049  Neurotrophic factor enhancer
0,235  0,053  UGT1A1 substrate
0,271  0,091  CTGF expression inhibitor
0,189  0,009  Estrogen agonist
0,174  0,003  Na+ K+ transporting ATPase inhibitor
0,302  0,134  Antibacterial
0,319  0,150  Alzheimer's disease treatment
0,209  0,043  Liver fibrosis treatment
0,261  0,097  Antipsoriatic
0,177  0,014  Nitric-oxide synthase inhibitor
0,250  0,087  Transcription factor STAT inhibitor
0,188  0,026  Farnesoid X receptor antagonist
0,170  0,009  UGT2B11 substrate
0,184  0,023  Adenylate cyclase stimulant
0,250  0,092  CYP2C19 substrate
0,166  0,009  Antiviral (Rhinovirus)
0,178  0,022  Choleretic
0,210  0,055  Sepsis treatment
0,228  0,079  Free radical scavenger
0,233  0,085  Antineoplastic (sarcoma)
0,162  0,019  Estrogen antagonist
0,188  0,045  Antineoplastic (squamous cell carcinoma)
0,189  0,048  Antineoplastic (carcinoma)
0,164  0,023  Protease inhibitor
0,167  0,029  Expectorant
0,137  0,004  Estrone sulfatase inhibitor
0,141  0,009  Bile acid receptor antagonist
0,136  0,004  RNA-directed RNA polymerase stimulant
0,139  0,007  5-Alpha-reductase inhibitor
0,213  0,086  Embryotoxic
0,207  0,082  Antiparkinsonian, rigidity relieving
0,139  0,014  CDC25A inhibitor
0,127  0,004  Heme oxygenase stimulant
0,209  0,086  UGT1A6 substrate
0,153  0,030  Antineoplastic antibiotic
0,157  0,036  Beta amyloid protein antagonist
0,137  0,015  Aromatase inhibitor
0,214  0,096  Acute neurologic disorders treatment
0,155  0,038  Growth stimulant
0,146  0,028  CC chemokine 6 receptor antagonist
0,217  0,108  UGT1A9 substrate
0,111  0,003  Cholesterol ester transfer protein antagonist
0,151  0,044  Antitussive
0,119  0,013  Glycine receptor agonist
0,149  0,043  Autism spectrum disorders treatment
0,129  0,024  SULT1E1 substrate
0,109  0,005  Diacylglycerol O-acyltransferase inhibitor
0,173  0,071  Antineoplastic (bone cancer)
0,172  0,071  Toxic, respiratory center
0,105  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,139  0,040  Shock treatment
0,175  0,076  Antirickettsial
0,118  0,020  3C-Like protease (SARS coronavirus) inhibitor
0,108  0,011  Transcription factor AP-1 inhibitor
0,123  0,031  Actinic keratosis treatment
0,095  0,007  Lipocortins synthesis agonist
0,095  0,011  SULT2A1 substrate
0,087  0,003  Tubulin agonist
0,148  0,070  Antidiabetic (type 1)
0,152  0,073  Antinephritic
0,085  0,009  Acetyl-CoA transferase 2 inhibitor
0,149  0,075  Phospholipase A2 inhibitor
0,135  0,062  Antihyperlipoproteinemic
0,084  0,011  Postcoital contraceptive
0,082  0,011  Estrogen receptor alpha agonist
0,082  0,014  Estrogen receptor beta agonist
0,137  0,070  Antifungal enhancer
0,073  0,006  Farnesoid X receptor agonist
0,111  0,045  Estrogen receptor beta antagonist
0,140  0,074  Pregnane X receptor agonist
0,116  0,052  UGT2B1 substrate
0,144  0,082  Cholinergic
0,113  0,051  Sulfotransferase substrate
0,105  0,044  ABCA1 expression enhancer
0,072  0,012  Progesterone antagonist
0,182  0,125  Myocardial infarction treatment
0,063  0,006  Glucose-6-phosphate dehydrogenase inhibitor
0,066  0,009  Microtubule stabilization
0,084  0,029  Anticholelithogenic
0,156  0,103  LDLR expression enhancer
0,077  0,025  Nitric oxide donor
0,116  0,066  Caspase 3 inhibitor
0,074  0,023  Acetyl-CoA transferase inhibitor
0,130  0,080  Psychosexual dysfunction treatment
0,190  0,141  Respiratory analeptic
0,057  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,170  0,123  Antineoplastic (lymphoma)
0,164  0,119  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,049  0,004  Toll-Like receptor 4 agonist
0,050  0,007  HMG CoA reductase inhibitor
0,116  0,073  Alcohol dehydrogenase substrate
0,223  0,183  Antiobesity
0,091  0,051  Antileprosy
0,043  0,004  Hedgehog signaling activator
0,054  0,017  Parathyroid hormone antagonist
0,176  0,140  RNA-directed DNA polymerase inhibitor
0,093  0,058  Paget's disease treatment
0,146  0,111  Antineoplastic (gastric cancer)
0,148  0,116  Anesthetic general
0,040  0,008  5-Alpha-reductase 2 inhibitor
0,048  0,016  Glucocorticoid antagonist
0,038  0,007  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,162  0,132  Platelet antagonist
0,035  0,005  Corticosteroid-like
0,184  0,155  Renal disease treatment
0,031  0,003  Telomerase stimulant
0,034  0,006  Progesterone agonist
0,068  0,040  CDC25B inhibitor
0,053  0,026  Cholesterol esterase inhibitor
0,143  0,119  Septic shock treatment
0,054  0,030  Anesthetic inhalation
0,032  0,008  5-Alpha-reductase 1 inhibitor
0,076  0,056  Estrogen receptor alpha antagonist
0,125  0,107  UGT1A3 substrate
0,045  0,028  Estradiol 17 beta-dehydrogenase inhibitor
0,074  0,058  Narcotic antagonist
0,041  0,027  Cholesterol absorption inhibitor
0,014  0,002  Transcortin receptor antagonist
0,029  0,017  1,3-Beta-glucan synthase inhibitor
0,071  0,061  SULT1A2 substrate
0,073  0,065  Chymotrypsin inhibitor
0,022  0,014  Vitamin D receptor antagonist
0,039  0,031  Liver X receptor alpha agonist
0,049  0,041  Protein 50S ribosomal subunit inhibitor
0,167  0,160  Antihypotensive
0,124  0,117  Antifungal (Cryptococcus)
0,060  0,054  Transcription factor RelA inhibitor
0,015  0,009  Glucocorticoid agonist
0,101  0,095  Amylase inhibitor
0,085  0,081  Posttraumatic stress disorder treatment
0,043  0,040  Dopamine transporter inhibitor
0,016  0,013  Vitamin D receptor agonist
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,117  0,116  Skeletal muscle relaxant
0,159  0,159  Interleukin agonist

